Outcome of the board meeting held on 23.09.2026 for withdrawal of agenda items from notice convening ensuing annual general meeting

Archit Organosys Limited 903, 9th Floor, Venus Benecia, Nr. Pakwan Restaurant, Bodakdev, S. G. Highway, Ahmedabad-380054, Gujarat, India. CIN: L24110G.11993PLC019941 Date: 23rd September, 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001. Dear Sir/ Ma’am, Sub: Outcome of Board Meeting held today i.e., Wednesday, 23rd September, 2026 Ref: BSE Scrip Code: 524640 | ISIN: INE078I01011 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, at its meeting held today, i.e., Wednesday, 23rd September, 2026, which commenced at 06:00 P.M. and concluded at 06:30 P.M., has considered and approved the withdrawal of the following agenda items from the Notice of the forthcoming Annual General Meeting of the Company to be convened on Wednesday, 30th September, 2026: Item Number 8 - Increase in Authorized Share Capital and consequent alteration of MOA of the company. Item Number 9 - Approval for the Acquisition of up to 1,36,24,172 (One Crore Thirty-Six Lakh Twenty- Four Thousand One Hundred Seventy-Two) equity shares i.e. 67.44% of the Equity Share Capital of M/s. Archit Life Science Limited form its selling shareholders as a Material Related Party Transaction. Item Number 10 - To Offer, Issue and Allot Equity Shares (Other than Cash) on a Preferential Basis. The Company has made its application for an “In-principal Approval” for the proposed preferential issue with the BSE Limited (“BSE”) which is in process. However, the management has decided to withdraw the aforesaid proposed preferential issue in its present form with a view to restructuring the proposed transaction. Consequently, Item Nos. 8, 9 and 10 have been withdrawn from the evoting and discussion at ensuing Annual General Meeting. The Company recognizes the importance of maintaining transparency and keeping its stakeholders duly informed. The withdrawal of the aforesaid proposals is being undertaken as part of the proposed restructuring of the transaction and, as of the date of this intimation, is not expected to have any adverse impact on the financial position or ongoing operations of the Company. The Company will make appropriate disclosures to the Stock Exchange in accordance with applicable laws and regulations, as and when required. Kindly take the same on your record and oblige us. Thanking You. For Archit Organosys Limited Kandarp Amin Chairman and Whole-time Director DIN: 00038972 Phone: +91-79-26873340/48925370 Unit: Survey No. 228/A, Paiki 7, Paiki 2, Village - Narmad, Bhavnagar-364313, Gujarat, India. E-MAIL: accounts@architorg.com | export@architorg.com | share@architorg.com | trading@architorg.com | Website: www.architorg.com